Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
Journal of Molecular and Cellular Cardiology
|
October 2, 2003
Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes
Mark Shilkrut, Gal Yaniv, Rabea Asleh, et al.
Nature Clinical Practice. Nephrology
|
May 26, 2007
Hypothesis--haptoglobin genotype and diabetic nephropathy
Farid M Nakhoul, Rachel Miller-Lotan, Huda Awaad, et al.
European Journal of Internal Medicine
|
October 11, 2020
Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation
Alexandros Briasoulis, Hiroki Ueyama, Toshiki Kuno, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Management of heart failure with reduced ejection fraction: challenges in patients with atrial fibrillation, renal disease and in the elderly
Yotam Kolben, Asa Kessler, Gal Puris, et al.
The American Journal of Cardiology
|
May 8, 2018
Regional Variation in Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014)
Alexandros Briasoulis, Chakradhari Inampudi, Emmanuel Akintoye, et al.
Pharmacogenomics and Personalized Medicine
|
December 11, 2012
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
Avery Schwartz, Shany Blum, Rabea Asleh, et al.
The Journal of Biological Chemistry
|
April 30, 2014
Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury
Rabea Asleh, John Ward, Nina S Levy, et al.
Comprehensive Physiology
|
August 7, 2024
Human Gut Microbiota in Cardiovascular Disease
Daniel Ronen, Yair Rokach, Suzan Abedat, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|
February 22, 2019
Trends in utilization, mortality, major complications, and cost after total artificial heart implantation in the United States (2009-2015)
Alexandros Briasoulis, Emmanuel Akintoye, Ala Mohsen, et al.
Vaccines
|
April 23, 2022
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Daniel Ronen, Aseel Bsoul, Michal Lotem, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
Journal of Molecular and Cellular Cardiology
|
October 2, 2003
Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes
Mark Shilkrut, Gal Yaniv, Rabea Asleh, et al.
Nature Clinical Practice. Nephrology
|
May 26, 2007
Hypothesis--haptoglobin genotype and diabetic nephropathy
Farid M Nakhoul, Rachel Miller-Lotan, Huda Awaad, et al.
European Journal of Internal Medicine
|
October 11, 2020
Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation
Alexandros Briasoulis, Hiroki Ueyama, Toshiki Kuno, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Management of heart failure with reduced ejection fraction: challenges in patients with atrial fibrillation, renal disease and in the elderly
Yotam Kolben, Asa Kessler, Gal Puris, et al.
The American Journal of Cardiology
|
May 8, 2018
Regional Variation in Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014)
Alexandros Briasoulis, Chakradhari Inampudi, Emmanuel Akintoye, et al.
Pharmacogenomics and Personalized Medicine
|
December 11, 2012
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
Avery Schwartz, Shany Blum, Rabea Asleh, et al.
The Journal of Biological Chemistry
|
April 30, 2014
Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury
Rabea Asleh, John Ward, Nina S Levy, et al.
Comprehensive Physiology
|
August 7, 2024
Human Gut Microbiota in Cardiovascular Disease
Daniel Ronen, Yair Rokach, Suzan Abedat, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|
February 22, 2019
Trends in utilization, mortality, major complications, and cost after total artificial heart implantation in the United States (2009-2015)
Alexandros Briasoulis, Emmanuel Akintoye, Ala Mohsen, et al.
Vaccines
|
April 23, 2022
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Daniel Ronen, Aseel Bsoul, Michal Lotem, et al.
Page
of 12